Ovarian Cancer Drug Study = Improvments in Survival

From: mdanderson
URL: http://www.mdan...
Type: Doctors and Experts
Joined: January 2008
Videos: 75

Share this video

Added: October 23, 2009 | Time 03:43 | Views: 191

Dr. Maurie Markman, vice president for clinical research talks about a study done in Japan with Paclitaxel and Carboplatin a standard drug regimen for the treatment of Ovarian Cancer.

The study results, published in The Lancet in September 2009 indicates that weekly Paclitaxel plus Carboplatin improved survival of women with epithelial ovarian cancer and may represent a new treatment option.

Topics: Ovarian Cancer

Tags: carboplatin, ovarian cancer, paclitaxel

Embed:

Comments

Post a Comment

Please log in at the top of the page to post a comment!

Scientist Wins Era of Hope Award for Breast Cancer
Posted By: mdanderson
Views: 184 Add to Favorites

Standard Imaging Taken Post Avastin May Predict Survival in Metastatic Colorectal Cancer Patients
Posted By: mdanderson
Views: 178 Add to Favorites

40 Years of Making Cancer History
Posted By: mdanderson
Views: 145 Add to Favorites

Tibetan Sound Meditation for Cancer Patients
Posted By: mdanderson
Views: 160 Add to Favorites

When Are Cancer Screenings Necessary?
Posted By: mdanderson
Views: 180 Add to Favorites

Chemo Brain
Posted By: mdanderson
Views: 187 Add to Favorites

Painting the Town Pink for Inflammatory Breast Cancer
Posted By: mdanderson
Views: 170 Add to Favorites

Navigation

Community

Site Links

Resources / Support

By using this service, you accept our Terms of Service. Please read them. The health information on this site is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen.